Hematology 2025_ Event Postponement

This is to inform that due to some circumstances beyond the organizer control, "2nd Edition of International Summit on Hematology and Blood Disorders" (Hematology 2025) June 05-07, 2025 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.

Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.

For further details, please contact us at hematology@magnusconference.com or call + 1 (702) 988 2320.

Blood based products

Any therapeutic substance obtained from human blood, including whole blood and other blood components for transfusion, as well as plasma-derived pharmaceutical compounds, is referred to as a blood product. Medicinal (medical therapeutic) products obtained from human blood and plasma donations play an important role in medical care. Every year, blood products that are safe, effective, and of high-quality help to improve and save millions of lives. Inadequate or unsafe blood supplies have a detrimental influence on the ability of critical health services and programmes to offer proper patient care in a variety of acute and chronic illnesses. Access to safe, effective, and quality-assured blood products for all patients who require transfusion is a critical component of a functional health system and essential for patient safety.